Kalyan, India

Ulhas Digambar Patil

This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2016.


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulhas Digambar Patil: Innovator in Pharmaceutical Processes

Introduction

Ulhas Digambar Patil is a notable inventor based in Kalyan, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. His work has been instrumental in advancing medical treatments and improving patient outcomes.

Latest Patents

Ulhas Digambar Patil holds a patent for a process titled "Process for the preparation of teneligliptin." This patent represents a crucial advancement in the synthesis of this important pharmaceutical compound, which is used in the treatment of type 2 diabetes. The patent showcases his expertise and commitment to enhancing drug formulation techniques. He has 1 patent to his name.

Career Highlights

Patil is currently employed at Glenmark Pharmaceuticals Limited, a leading global pharmaceutical company. His role involves research and development, where he focuses on creating innovative solutions to meet healthcare needs. His contributions have not only benefited his company but have also had a positive impact on the pharmaceutical industry as a whole.

Collaborations

Throughout his career, Ulhas has collaborated with talented professionals, including Suresh Mahadev Kadam and Bipin Parsottam Kansagra. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Ulhas Digambar Patil is a distinguished inventor whose work in pharmaceutical processes has made a significant impact. His dedication to innovation and collaboration continues to drive advancements in the field, ultimately benefiting patients and healthcare providers alike.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…